ANIK
Price:
$14.72
Market Cap:
$195.86M
Anika Therapeutics, Inc. is a company dedicated to joint preservation, innovating and providing early intervention orthopedic care across the globe, including the United States and Europe. Their core focus areas include osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and advanced bone-preserving joint technologies. All of Anika's products are developed, manufactured, and commercialized utilizing their proprietary hyaluronic acid (HA) technology platform. Their comprehensive product lines feature an OA pain management family, which includes established treatments like Monovisc, Orthovisc, Cingal, and Hyvisc, all designed to alleviate discomfort from osteoarthr...[Read more]
Industry
Medical - Devices
IPO Date
1993-05-03
Stock Exchange
NASDAQ
Ticker
ANIK
According to Anika Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -7.74%. This represents a change of 294.46% compared to the average of -1.96% of the last 4 quarters.
The mean historical ROE of Anika Therapeutics, Inc. over the last ten years is -5.25%. The current -7.74% ROE has changed 47.41% with respect to the historical average. Over the past ten years (40 quarters), ANIK's ROE was at its highest in in the June 2017 quarter at 4.66%. The ROE was at its lowest in in the December 2023 quarter at -29.68%.
Average
-5.25%
Median
-1.88%
Minimum
-38.95%
Maximum
14.61%
Discovering the peaks and valleys of Anika Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 648.46%
Maximum Annual ROE = 14.61%
Minimum Annual Increase = -461.35%
Minimum Annual ROE = -38.95%
| Year | ROE | Change |
|---|---|---|
| 2025 | -7.58% | -79.29% |
| 2024 | -36.62% | -5.98% |
| 2023 | -38.95% | 648.46% |
| 2022 | -5.20% | -461.35% |
| 2021 | 1.44% | -116.36% |
| 2020 | -8.80% | -193.36% |
| 2019 | 9.43% | 32.77% |
| 2018 | 7.10% | -41.18% |
| 2017 | 12.07% | -17.35% |
| 2016 | 14.61% | 0.15% |
The current ROE of Anika Therapeutics, Inc. (ANIK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-27.72%
5-year avg
-17.38%
10-year avg
-5.25%
Anika Therapeutics, Inc.’s ROE is less than Owlet, Inc. (1.14%), greater than LENSAR, Inc. (-514.92%), greater than Apyx Medical Corporation (-90.62%), greater than Anteris Technologies Global Corp. (-124.40%), greater than Lucid Diagnostics Inc. (-370.21%), greater than Rapid Micro Biosystems, Inc. (-131.52%), greater than Anixa Biosciences, Inc. (-65.73%), greater than Accuray Incorporated (-77.48%), greater than MaxCyte, Inc. (-22.03%), greater than Quipt Home Medical Corp. (-10.47%),
| Company | ROE | Market cap |
|---|---|---|
| 1.14% | $84.14M | |
| -514.92% | $70.45M | |
| -90.62% | $196.39M | |
| -124.40% | $336.61M | |
| -370.21% | $98.28M | |
| -131.52% | $79.77M | |
| -65.73% | $84.04M | |
| -77.48% | $40.60M | |
| -22.03% | $119.98M | |
| -10.47% | $162.30M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anika Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Anika Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Anika Therapeutics, Inc.'s ROE?
How is the ROE calculated for Anika Therapeutics, Inc. (ANIK)?
What is the highest ROE for Anika Therapeutics, Inc. (ANIK)?
What is the 3-year average ROE for Anika Therapeutics, Inc. (ANIK)?
What is the 5-year average ROE for Anika Therapeutics, Inc. (ANIK)?
How does the current ROE for Anika Therapeutics, Inc. (ANIK) compare to its historical average?